Cargando…

Predicting response to recombinant activated factor VIIa administration in the critically ill

Detalles Bibliográficos
Autores principales:	Pugh, R, Wenstone, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088594/ http://dx.doi.org/10.1186/cc6444

Ejemplares similares

Does recombinant factor VIIa change the inflammatory response to trauma? Preliminary results of inflammatory biomarkers in critically ill trauma patients
por: Lissauer, M, et al.
Publicado: (2006)

Thromboembolic risks of recombinant factor VIIa use in warfarin-associated intracranial hemorrhage
por: Chou, S, et al.
Publicado: (2011)

The use of recombinant factor VIIa as a haemostatic agent in ICU patients
por: Vernikos, P, et al.
Publicado: (2004)

Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma
por: Mohr, Alicia M, et al.
Publicado: (2005)

Equipment-related critical incidents in a general intensive care unit
por: King, AT, et al.
Publicado: (2015)

Early use of factor VIIa in cardiac surgery is associated with lower rates of blood transfusions without impact on outcome
por: Galas, F, et al.
Publicado: (2010)

Frailty measures in the critically ill: are we approaching a critical age? A systematic review
por: Pugh, R, et al.
Publicado: (2014)

Predicting a low response to ACTH in the critically ill
por: de Jong, M, et al.
Publicado: (2006)

Preclinical trauma studies of recombinant factor VIIa
por: Schreiber, Martin A, et al.
Publicado: (2005)

Anti-activated factor × response to enoxaparin in critically ill patients
por: Einav, S, et al.
Publicado: (2009)

Recombinant human erythropoietin therapy in critically ill patients
por: Georgopoulos, D, et al.
Publicado: (2005)

Recombinant Activated Factor VIIa Treatment for Refractory Hemorrhage in Infants
por: Dang, Chi N, et al.
Publicado: (2010)

Survival of critically ill patients with haematological malignancies compared with patients without haematological malignancy
por: Pugh, R, et al.
Publicado: (2013)

Acute exercise response in the critically ill
por: Collings, N, et al.
Publicado: (2013)

Use of recombinant factor VIIa in orthotopic liver transplant
por: Bhatia, Pradeep
Publicado: (2011)

Effect of haemodilution, acidosis, and hypothermia on the activity of recombinant factor VIIa (NovoSeven(®))
por: Viuff, D., et al.
Publicado: (2008)

Brachial cuff measurements for fluid responsiveness prediction in the critically ill
por: Lakhal, K, et al.
Publicado: (2011)

Critically ill obstetric patients: outcome and predictability
por: Haddad, Z, et al.
Publicado: (2005)

Pharmacological characteristics of a novel, recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP)
por: Zollner, S, et al.
Publicado: (2014)

Pleth Variability Index predicts fluid responsiveness in critically ill patients
por: Nanadoumgar, H, et al.
Publicado: (2011)

Oral chlorhexidine to prevent nosocomial pneumonia in critically ill patients: a systematic review and meta-analysis
por: Pugh, RJ, et al.
Publicado: (2010)

Cost effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage
por: Kissela, Brett M, et al.
Publicado: (2008)

Recombinant factor VIIa in severe trauma: further study needed
por: Galvan, Dan A, et al.
Publicado: (2006)

Recombinant Factor VIIa: Hemostatic Adjunct in the Coagulopathic Burn Patient
por: Martin, Jeremiah T., et al.
Publicado: (2009)

The utility of recombinant factor VIIa as a last resort in trauma
por: Mamtani, Rishi, et al.
Publicado: (2012)

Recombinant factor VIIa use in patients presenting with intracranial hemorrhage
por: Yampolsky, Natalie, et al.
Publicado: (2014)

Glucose absorption following gastric and small intestinal nutrient administration in the critically ill
por: Chapman, M, et al.
Publicado: (2011)

Recurrence of Gram-negative nosocomial pneumonia in the critically ill patient following short-course antibiotic therapy
por: Pugh, Richard, et al.
Publicado: (2007)

Fluid responsiveness predicted by transcutaneous partial pressure of oxygen in critically ill patients
por: Xu, J, et al.
Publicado: (2015)

Renal replacement in critically ill patients: the age factor
por: Occhigrossi, F, et al.
Publicado: (2004)

Arrhythmia incidence and risk factors in critically ill patients
por: Tasdemir, G, et al.
Publicado: (2015)

Response of NICOM stroke volume to passive leg raising to predict fluid responsiveness in critically ill patients with spontaneous breathing activity
por: Lamia, B, et al.
Publicado: (2010)

Continuous vs bolus administration of imipenem in critically ill patients with ICU-acquired pneumonia
por: Sakka, S, et al.
Publicado: (2004)

Effect of critical illness on the pharmacokinetics and dose-response relationship of midazolam
por: Ovakim, D, et al.
Publicado: (2012)

Diffuse alveolar hemorrhage and recombinant factor VIIa treatment in pediatric patients
por: Park, Jeong A
Publicado: (2016)

Critical illness polyneuropathy: incidence and risk factors
por: Meyer, B, et al.
Publicado: (2006)

Risk factors for death in chronic critical illness
por: Lokhandwala, S, et al.
Publicado: (2015)

The effect of nutrition and severity of illness on blood vitamin concentrations in critically ill patients
por: Hill, SE, et al.
Publicado: (1997)

Effectiveness and safety of recombinant activated factor
por: Echarri González, G, et al.
Publicado: (2006)

Reduced responsiveness of blood leukocytes to lipopolysaccharide does not predict nosocomial infections in critically ill patients
por: Van Vught, LA, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_f7g6ip9pvqn21bvpc5snuebn8e